Cifurtilimab, CAS 1629760-27-5

Product Description: Cifurtilimab (SEA-CD40) is an agonistic nonfucosylated, human IgG1 monoclonal antibody directed against CD40. Cifurtilimab shows antitumor activities[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Neff-LaFord H, et al. SEA-CD40 is a non-fucosylated anti-CD40 antibody with potent pharmacodynamic activity in preclinical models and patients with advanced solid tumors. Cancer Research, 2020, 80(16_Supplement): 5535-5535./[2]Zeng W, et al. 438 Synergy between SEA-CD40 and chemotherapeutics drives curative antitumor activity in preclinical models. 2020.

CAS Number: 1629760-27-5

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: H2O

Target: Others

• Artikelnummer: MEXHY-P99603-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99603-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated